MACROGENICS INC — Director's Dealing 2017

Apr 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-04-19

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-19	Common Stock	M	15000	$4.70	Acquired	45000	Direct
2017-04-19	Common Stock	S	15000	$20	Disposed	30000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-19	Employee stock option (right to buy)	$4.7	M	15000	Disposed	2023-07-18	Common Stock (15000.0)	Direct

Footnotes

F1: The sales reported in this form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on December 15, 2016.

F2: This transaction was executed in multiple trades at prices ranging from $20 to $20.03.

F3: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which vest on 2/25/18.